# Tompkins Financial Corp: overview

TMP · NYSE · CIK 1005817 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tmp.md) · [Financials](/companies/tmp/financials.md) · [Filings](/companies/tmp/filings.md) · [Insiders](/companies/tmp/insiders.md)

Latest reported revenue: [$21.5m](/filings/0001005817-25-000117.md) for Q1 FY2025, three months to 2025-03-31, from the 10-Q/A filed Nov 18, 2025 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001005817-25-000117).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [21.3](/filings/0001005817-24-000027.md) | [18.5 d](/filings/0001005817-26-000027.md) | [21.5](/filings/0001005817-25-000117.md) | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [87.5%](/filings/0001005817-25-000115.md) | [106.3% d](/filings/0001005817-26-000027.md) | [91.5%](/filings/0001005817-26-000049.md) | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [1.30](/filings/0001005817-25-000115.md) | not reported | [1.37](/filings/0001005817-26-000049.md) | [1.50](/filings/0001005817-26-000112.md) | [1.65](/filings/0001005817-25-000115.md) | not reported | [1.82](/filings/0001005817-26-000049.md) | [2.04](/filings/0001005817-26-000112.md) |
| Free cash flow | $m | [18.9 d](/filings/0001005817-25-000115.md) | [21.7 d](/filings/0001005817-26-000027.md) | [20.9](/filings/0001005817-26-000049.md) | [17.3 d](/filings/0001005817-26-000112.md) | [34.9 d](/filings/0001005817-25-000115.md) | [(41.1) d](/filings/0001005817-26-000027.md) | [71.1](/filings/0001005817-26-000049.md) | [(17.1) d](/filings/0001005817-26-000112.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [72.6](/filings/0001005817-24-000008.md) | [74.0](/filings/0001005817-25-000006.md) | [75.0](/filings/0001005817-26-000027.md) | [79.3](/filings/0001005817-26-000027.md) | [75.7](/filings/0001005817-26-000027.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [123.0%](/filings/0001005817-24-000008.md) | [114.9%](/filings/0001005817-25-000006.md) | [12.7%](/filings/0001005817-26-000027.md) | [89.3%](/filings/0001005817-26-000027.md) | [212.7%](/filings/0001005817-26-000027.md) |
| Diluted EPS | $ per share | [6.05](/filings/0001005817-24-000008.md) | [5.89](/filings/0001005817-25-000006.md) | [0.66](/filings/0001005817-26-000027.md) | [4.97](/filings/0001005817-26-000027.md) | [11.24](/filings/0001005817-26-000027.md) |
| Free cash flow | $m | [116](/filings/0001005817-24-000008.md) | [95.2](/filings/0001005817-25-000006.md) | [82.2](/filings/0001005817-26-000027.md) | [88.8](/filings/0001005817-26-000027.md) | [31.9](/filings/0001005817-26-000027.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/tmp/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $193.7m | 2,049,724 |  | Added +47,391 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $114.2m | 1,207,855 |  | Added +21,501 |
| [TOMPKINS FINANCIAL CORP](/funds/1005817.md) | 2026-06-30 | $105.6m | 1,117,319 |  | Reduced −2,024 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $72.5m | 767,435 |  | Added +13,436 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $57.4m | 607,495 |  | Added +20,029 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $53.9m | 570,388 |  | Added +4,451 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $39.0m | 412,614 |  | Added +105,272 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $35.0m | 370,542 |  | Added +22,229 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $15.8m | 166,711 |  | Reduced −480 |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $13.9m | 146,925 |  | Added +9,762 |

## Recent filings

[All 1,850 filings](/companies/tmp/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 09:23 ET | [8-K](/filings/0001005817-26-000139.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001005817-26-000139 |
| 2026-07-31 | 17:28 ET | [10-Q](/filings/0001005817-26-000112.md) | Quarterly report, period 2026-06-30 | 0001005817-26-000112 |
| 2026-07-28 | 13:55 ET | [8-K](/filings/0001005817-26-000105.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005817-26-000105 |
| 2026-07-24 | 13:02 ET | [8-K](/filings/0001005817-26-000087.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001005817-26-000087 |
| 2026-05-26 | 15:06 ET | [8-K](/filings/0001999371-26-011418.md) | 5.07 Shareholder vote results | 0001999371-26-011418 |
| 2026-05-19 | 15:14 ET | [8-K](/filings/0001999371-26-011044.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001999371-26-011044 |
| 2026-05-05 | 14:15 ET | [10-Q](/filings/0001005817-26-000049.md) | Quarterly report, period 2026-03-31 | 0001005817-26-000049 |
| 2026-04-27 | 16:17 ET | [8-K](/filings/0001999371-26-009123.md) | 5.02 Departure or appointment of officers or directors | 0001999371-26-009123 |
| 2026-04-24 | 13:03 ET | [8-K](/filings/0001005817-26-000045.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001005817-26-000045 |
| 2026-04-06 | 20:15 ET | [DEF 14A](/filings/0001140361-26-013350.md) | Proxy statement, period 2026-05-19 | 0001140361-26-013350 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001005817-26-000027.md), filed Feb 26, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1005817
- Tickers: TMP
- Exchange: NYSE
- SIC code: 6022 State Commercial Banks
- State of incorporation: NY
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.